Znn3bq.jpeg
²é¿´: 1609  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

snqing

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] ÕªÒª-ÖÐÎÄ·­Òë³ÉÓ¢ÎÄ£¨ÇëÎðÓûúÆ÷·­£©

ÐÂÒ©Ñз¢ÓÉÓÚÆä¸ß·çÏÕ¡¢¸ßͶÈë¡¢³¤ÖÜÆÚ£¬ÒÔ¼°É漰ѧ¿ÆÁìÓò¹ã·º£¬ÐèÒªÌØ±ðÑо¿×ÊÖʵÈÌØµã£¬´Ó³É±¾ºÍ×ÊÔ´ÉÏ¿¼ÂÇ£¬ÐèÒªÖÆÒ©ÆóÒµ¡¢ÐÂÒ©Ñз¢ÆóÒµÒÔ¼°¿ÆÑÐÔºËùÖ®¼ä½øÐкÏ×÷Ñз¢¡£ÐÂÒ©ºÏ×÷Ñз¢ÊÇÒ»¸ö·Ç³£¸´ÔӵĹý³Ì£¬ÒªÓëºÏ×÷µ¥Î»¹²Í¬½øÐÐСÊÔ¡¢ÖÐÊÔ¡¢ÁÙ´²ÊÔÑé¡¢×¢²áÉ걨ºó²ÅÄÜÉÏÊÐÏúÊÛ¡£¿ªÕ¹ÐÂÒ©ºÏ×÷Ñз¢ÏîÄ¿½ø¶È¹ÜÀíÑо¿£¬ÒÔ¼Ó¿ìÐÂÒ©Ñз¢ËÙ¶È£¬Ëõ¶ÌÐÂÒ©Ñз¢ÖÜÆÚ£¬Ìá¸ßÑз¢Ð§ÂÊ£¬ÒѾ­³ÉΪÆóÒµ±ØÐ뿪չµÄÒ»ÏîÖØÒª¹¤×÷¡£
±¾ÎÄÒÔÐÂÒ©NMFµÄÑз¢ÏîĿΪÀý£¬¶ÔÐÂÒ©µÄºÏ×÷Ñз¢ÏîÄ¿ÔÚÏîÄ¿½ø¶È¼Æ»®Öƶ¨ºÍ½ø¶È¿ØÖÆ·½Ãæ½øÐÐÁËÑо¿¡£Ê×ÏÈ£¬ÔÚ¶Ô¹úÄÚÍâÏîÄ¿½ø¶È¹ÜÀíÑо¿ÏÖ×´ºÍÏà¹ØÀíÂÛ½øÐмòÒª·ÖÎöµÄ»ù´¡ÉÏ£¬¶ÔNMFÐÂÒ©ÏîÄ¿µÄÔË×÷Ìåϵ½øÐÐÁËÂÛÊö£¬·ÖÎöÁËÓ°ÏìÏîÄ¿Ñз¢½ø¶ÈµÄÖ÷ÒªÒòËØ£¬¶ÔÏîÄ¿µÄ×éÖ¯»ú¹¹¡¢ÏîÄ¿Ñз¢Á÷³ÌºÍÔË×÷ÌåϵµÈ½øÐÐÁ˽éÉÜ¡£Æä´Î£¬ÀûÓýø¶È¹ÜÀíÏà¹ØÀíÂۺͷ½·¨¶ÔÏîÄ¿µÄ½ø¶È¼Æ»®Öƶ¨½øÐÐÁËÑо¿£¬ÔÚ¶ÔÍøÂç¼Æ»®¼¼Êõ½øÐгä·ÖÁ˽âµÄ»ù´¡ÉÏ£¬·ÖÎöÁËÐÂÒ©ÏîÄ¿Ñз¢Á÷³Ì£¬ÀûÓù¤×÷·Ö½â½á¹¹£¬CPM·¨¡¢Microsoft ProjectÈí¼þµÈ·½·¨ºÍ¹¤¾ßÖÆ¶¨ÁËÏîÄ¿µÄ½ø¶È¼Æ»®¡£µÚÈý£¬½éÉÜÁËÔÚÏîÄ¿½ø¶È¿ØÖÆ·½ÃæËù²ÉÈ¡µÄ´ëÊ©ºÍ·½·¨£¬²ÉÓýø¶È¶¯Ì¬¸ú×ÙÓë¿ØÖÆµÄ·½·¨½â¾öÏîÄ¿ÔÚʵʩ¹ý³ÌÖвúÉúµÄ½ø¶ÈÎÊÌ⣬²¢Í¨¹ý¶Ô½ø¶È¼Æ»®µÄ¼°Ê±¸üУ¬È·±£ÏîÄ¿×ܽø¶È²»ÊÜÓ°Ïì¡£×îºó£¬ÔÚ´ËÏîÄ¿µÄ»ù´¡ÉÏ£¬¶ÔÐÂÒ©ºÏ×÷Ñз¢¹ý³ÌÖ÷ÒªÓ°ÏìÒòËØ½øÐÐÁË·ÖÎö£¬×ܽáÁËÔÚ±¾ÏîÄ¿½ø¶È¹ÜÀíºÍ¿ØÖÆ·½ÃæµÄ¾­Ñ飬Ìá³öÁ˸ĽøÒâ¼ûºÍ½¨Òé¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
°®ÓëÓêÏÂ: ½ð±Ò+1 2013-12-27 22:44:44
snqing: ½ð±Ò+100, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú, »¹ÐУ¬¾ÍÊdz¤¾ä×ÓÓеã¶ù¶à 2013-12-28 18:19:05
Development of new drugs is characterized by high risk, high investment and long cycle times and involves multiple disciplines. In addition, it requires special research qualifications. Therefore, considering the cost and resources, a collaborative research and development between drug manufacturers, new drug development companies and research institutions is required. This new drug research and development is a very complicated process in which the partners must jointly carry through  lab test, pilot test, clinical test and drug registration application before the drugs can be launched for sale.  To carry out research on progress management in  collaborative development projects for new drugs such that new drug development is sped up, development cycle times shortened and overall development efficiency enhanced, has become an important work for enterprises to do.

This paper uses the development project for the new drug NMF as example and studies the project progress plans and progress controls in collaborative development projects for new drugs. To start with, based on a brief review of the current research of project progress management in China and abroad and related theories, the operational framework for the NMF new drug project is described,  the major factors influencing the project development progress are analysed and organisation structure, project development processes and operational framework are presented. Secondly, by means of theories and methods for progress management, how the project progress plan is set up, is researched. Based on a thorough understanding of network scheduling techniques, the new drug development project process is analysed. Using work breakdown structures, software and methods such as CPM and Microsoft Project are used to create the progress plan for the project. Next, measures and methods used for controlling project progress are described. With the method of progress dynamic tracking and control, problems with progress arising during project  execution are solved. By prompt updates of the progress plan, the overall project progress is assured unaffected. Lastly,  based on the project, the main influencing factors for new drug collaborative development are analysed, the experiences gained in progress management and control of the project summarized and comments and recommendations made for improvements.
·Ç»úÆ÷·­Ò룬½ö¹©²Î¿¼
Befairorbeaware
2Â¥2013-12-27 21:14:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ snqing µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¼±Ðèµ÷¼Á +7 ¾ø²»·ÅÆú22 2026-04-15 8/400 2026-04-17 23:54 by ¾ø²»·ÅÆú22
[¿¼ÑÐ] Çóµ÷¼Á +9 СÄô°®Ñ§Ï° 2026-04-16 11/550 2026-04-17 22:34 by chixmc
[¿¼ÑÐ] 304Çóµ÷¼Á +7 castLight 2026-04-16 7/350 2026-04-17 20:05 by ¹ØÒ»ÕµµÆcd
[¿¼²©] Ç󲩵¼£üÉúÎïÖÊ»ù¶à¿×̼/³¬¼¶µçÈÝ·½Ïò£¬ÒÑÓÐÏà¹Ø³É¹û£¬Ñ°ÄÜÔ´²ÄÁÏ/̼²ÄÁÏ·½ÏòÀÏʦ +3 ÖíÖíÈËZzz 2026-04-12 3/150 2026-04-17 19:10 by ÑôÑôÑô^_^
[¿¼ÑÐ] 279Çóµ÷¼Á +13 ÕÅ·¬ÇѲ»³´µ° 2026-04-11 13/650 2026-04-17 10:38 by cuisz
[ÂÛÎÄͶ¸å] ÓÐûÓнÓÊձȽϿìµÄsciÆÚ¿¯Ñ½£¬×îºÃÔÚÒ»¸öÔÂÖ®Äڵģ¬ÑÐÈýº¢×ÓÇó±ÏÒµ 20+4 Ö®»¤×Å 2026-04-16 5/250 2026-04-17 10:02 by bobvan
[¿¼ÑÐ] ¿ÒÇëÓÐѧУÊÕÁô +8 ¿Â»´È» 2026-04-12 8/400 2026-04-17 09:34 by Öí»á·É
[¿¼ÑÐ] 294Çóµ÷¼Á +14 µ­È»654321 2026-04-15 14/700 2026-04-16 21:01 by lpl364211
[¿¼ÑÐ] 26ҩѧר˶105500Çóµ÷¼Á +6 à¶¹þ¼ÓÓÍ 2026-04-13 7/350 2026-04-16 14:31 by zhouxiaoyu
[¿¼ÑÐ] 279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ 20+7 ¹Â¶ÀµÄÀǰ®³ÔÑò 2026-04-12 29/1450 2026-04-16 09:00 by screening
[¿¼ÑÐ] 297£¬¹¤¿Æµ÷¼Á? +10 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-14 10/500 2026-04-15 21:50 by noqvsozv
[¿¼ÑÐ] 0854µ÷¼Á +13 ³¤¹­°Á 2026-04-12 16/800 2026-04-15 13:45 by fenglj492
[½Ìʦ֮¼Ò] ת³¤Æ¸ÁË +7 ¼òµ¥»¯xn 2026-04-13 7/350 2026-04-14 14:50 by xindong
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á +24 Ò¶zilin 2026-04-13 25/1250 2026-04-14 09:20 by ÊÔ¹ÜÆÆÁÑ
[¿¼ÑÐ] Çóµ÷¼Á +3 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 3/150 2026-04-14 01:00 by Íõ¬Bè±
[¿¼ÑÐ] Çóµ÷¼Á£¬985²ÄÁÏÓ뻯¹¤348·Ö +9 º­ÖñÁõ 2026-04-11 14/700 2026-04-13 22:26 by º­ÖñÁõ
[¿¼ÑÐ] 339Çóµ÷¼Á +4 hanwudada 2026-04-12 4/200 2026-04-13 12:03 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 346·Ö£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +6 moser233 2026-04-12 7/350 2026-04-12 22:11 by fqwang
[¿¼ÑÐ] 270Çóµ÷¼Á +14 ÑîÀÖ369 2026-04-11 14/700 2026-04-11 20:16 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸985»úеѧ˶380Çóµ÷¼Á +5 ¹Ø¹ØöÂð¯10 2026-04-11 5/250 2026-04-11 10:10 by ÖªÄî¡£A
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û